Vacant Lot Greening and Violence-Related Outcomes
|ClinicalTrials.gov Identifier: NCT01336374|
Recruitment Status : Completed
First Posted : April 15, 2011
Last Update Posted : December 5, 2011
|Condition or disease|
|Violence Prevention Built Environment|
|Study Type :||Observational|
|Actual Enrollment :||29 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||A Pilot Randomized Controlled Trial of Vacant Lot Greening and Violence-related Outcomes|
|Study Start Date :||April 2011|
|Primary Completion Date :||August 2011|
|Study Completion Date :||September 2011|
Greened Vacant Lot
A cluster of vacant lots is greened. People living around this area make up this cohort.
The control site is a cluster of vacant lots that will not be greened. The people living around these lots make up the control group.
- Perceptions of safety and violence [ Time Frame: measured twice - once during first month of study and once during 4th or 5th month. ]We will be performing qualitative interviews to assess perceptions of safety and violence. We will compare these perceptions over time between two groups.
- Heart Rate [ Time Frame: measured twice - once during first month of study and once during 4th or 5th month of study ]Participants wear a heart rate monitor during a walk around their neighborhood.
- Violent crime statistics [ Time Frame: Measured 6 months before intervention and 6 months after intervention ]We will obtain crime statistics, including homicide, robbery, rape, and assault in the area around each cluster of vacant lots.
- Safe/Unsafe items in the environment [ Time Frame: measured twice - once during the first month of the study and once during the 4th or 5th month. ]During a walk around the neighborhood, participants will point out items in the environment which they feel are safe or unsafe.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01336374
|United States, Pennsylvania|
|University of Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19104|
|Principal Investigator:||Eugenia C Garvin, MD||University of Pennsylvania|